171 related articles for article (PubMed ID: 27193296)
1. Individual-based versus aggregate meta-analysis in multi-database studies of pregnancy outcomes: the Nordic example of selective serotonin reuptake inhibitors and venlafaxine in pregnancy.
Selmer R; Haglund B; Furu K; Andersen M; Nørgaard M; Zoëga H; Kieler H
Pharmacoepidemiol Drug Saf; 2016 Oct; 25(10):1160-1169. PubMed ID: 27193296
[TBL] [Abstract][Full Text] [Related]
2. Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design.
Furu K; Kieler H; Haglund B; Engeland A; Selmer R; Stephansson O; Valdimarsdottir UA; Zoega H; Artama M; Gissler M; Malm H; Nørgaard M
BMJ; 2015 Apr; 350():h1798. PubMed ID: 25888213
[TBL] [Abstract][Full Text] [Related]
3. Maternal Use of Specific Antidepressant Medications During Early Pregnancy and the Risk of Selected Birth Defects.
Anderson KN; Lind JN; Simeone RM; Bobo WV; Mitchell AA; Riehle-Colarusso T; Polen KN; Reefhuis J
JAMA Psychiatry; 2020 Dec; 77(12):1246-1255. PubMed ID: 32777011
[TBL] [Abstract][Full Text] [Related]
4. In utero exposure to venlafaxine, a serotonin-norepinephrine reuptake inhibitor, increases cardiac anomalies and alters placental and heart serotonin signaling in the rat.
Laurent L; Huang C; Ernest SR; Berard A; Vaillancourt C; Hales BF
Birth Defects Res A Clin Mol Teratol; 2016 Dec; 106(12):1044-1055. PubMed ID: 27384265
[TBL] [Abstract][Full Text] [Related]
5. Selective serotonin reuptake inhibitors during pregnancy and risk of stillbirth and infant mortality.
Stephansson O; Kieler H; Haglund B; Artama M; Engeland A; Furu K; Gissler M; Nørgaard M; Nielsen RB; Zoega H; Valdimarsdóttir U
JAMA; 2013 Jan; 309(1):48-54. PubMed ID: 23280224
[TBL] [Abstract][Full Text] [Related]
6. Serotonin-Norepinephrine Reuptake Inhibitors and the Risk of AKI: A Cohort Study of Eight Administrative Databases and Meta-Analysis.
Renoux C; Lix LM; Patenaude V; Bresee LC; Paterson JM; Lafrance JP; Tamim H; Mahmud SM; Alsabbagh MW; Hemmelgarn B; Dormuth CR; Ernst P;
Clin J Am Soc Nephrol; 2015 Oct; 10(10):1716-22. PubMed ID: 26231193
[TBL] [Abstract][Full Text] [Related]
7. Antidepressant use in pregnancy and severe cardiac malformations: Danish register-based study.
Kolding L; Ehrenstein V; Pedersen L; Sandager P; Petersen OB; Uldbjerg N; Pedersen LH
BJOG; 2021 Nov; 128(12):1949-1957. PubMed ID: 34036715
[TBL] [Abstract][Full Text] [Related]
8. Risk of stress cardiomyopathy associated with selective serotonin reuptake inhibitors and serotonin and norepinephrine reuptake inhibitors: a real-world pharmacovigilance analysis.
Tan B; Chen L; Yan S; Pan H; Zhang J; Wei H
Sci Rep; 2024 Jul; 14(1):15167. PubMed ID: 38956425
[TBL] [Abstract][Full Text] [Related]
9. SSRI and SNRI use during pregnancy and the risk of persistent pulmonary hypertension of the newborn.
Bérard A; Sheehy O; Zhao JP; Vinet É; Bernatsky S; Abrahamowicz M
Br J Clin Pharmacol; 2017 May; 83(5):1126-1133. PubMed ID: 27874994
[TBL] [Abstract][Full Text] [Related]
10. Selective serotonin reuptake inhibitor or serotonin-norepinephrine reuptake inhibitors and epidemiological characteristics associated with prenatal diagnosis of congenital heart disease.
Melov SJ; Shetty PS; Pasupathy D; Kirby A; Sholler GF; Winlaw DS; Alahakoon TI
Prenat Diagn; 2021 Jan; 41(1):35-42. PubMed ID: 33067884
[TBL] [Abstract][Full Text] [Related]
11. Use of selective serotonin reuptake inhibitors in pregnancy and cardiac malformations: a propensity-score matched cohort in CPRD.
Margulis AV; Abou-Ali A; Strazzeri MM; Ding Y; Kuyateh F; Frimpong EY; Levenson MS; Hammad TA
Pharmacoepidemiol Drug Saf; 2013 Sep; 22(9):942-51. PubMed ID: 23733623
[TBL] [Abstract][Full Text] [Related]
12. Maternal and fetal outcomes following exposure to duloxetine in pregnancy: cohort study.
Huybrechts KF; Bateman BT; Pawar A; Bessette LG; Mogun H; Levin R; Li H; Motsko S; Scantamburlo Fernandes MF; Upadhyaya HP; Hernandez-Diaz S
BMJ; 2020 Feb; 368():m237. PubMed ID: 32075794
[TBL] [Abstract][Full Text] [Related]
13. Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants in Pregnancy and Congenital Anomalies: Analysis of Linked Databases in Wales, Norway and Funen, Denmark.
Jordan S; Morris JK; Davies GI; Tucker D; Thayer DS; Luteijn JM; Morgan M; Garne E; Hansen AV; Klungsøyr K; Engeland A; Boyle B; Dolk H
PLoS One; 2016; 11(12):e0165122. PubMed ID: 27906972
[TBL] [Abstract][Full Text] [Related]
14. Selective serotonin reuptake inhibitor antidepressant use in first trimester pregnancy and risk of specific congenital anomalies: a European register-based study.
Wemakor A; Casson K; Garne E; Bakker M; Addor MC; Arriola L; Gatt M; Khoshnood B; Klungsoyr K; Nelen V; O'Mahoney M; Pierini A; Rissmann A; Tucker D; Boyle B; de Jong-van den Berg L; Dolk H
Eur J Epidemiol; 2015 Nov; 30(11):1187-98. PubMed ID: 26148560
[TBL] [Abstract][Full Text] [Related]
15. Effects of in-utero exposure to selective serotonin reuptake inhibitors and venlafaxine on term and preterm infants.
Hogue AN; Temple-Cooper ME; Lagzdins M; Worley S; Scwersenski J; Floyd R; Saker F
J Neonatal Perinatal Med; 2017; 10(4):371-380. PubMed ID: 29286926
[TBL] [Abstract][Full Text] [Related]
16. Hepatic outcomes among adults taking duloxetine: a retrospective cohort study in a US health care claims database.
Lin ND; Norman H; Regev A; Perahia DG; Li H; Chang CL; Dore DD
BMC Gastroenterol; 2015 Oct; 15():134. PubMed ID: 26467777
[TBL] [Abstract][Full Text] [Related]
17. Venlafaxine: more dangerous than most "selective" serotonergic antidepressants.
Prescrire Int; 2016 Apr; 25(170):96-9. PubMed ID: 27186622
[TBL] [Abstract][Full Text] [Related]
18. Increased risk of severe congenital heart defects in offspring exposed to selective serotonin-reuptake inhibitors in early pregnancy--an epidemiological study using validated EUROCAT data.
Knudsen TM; Hansen AV; Garne E; Andersen AM
BMC Pregnancy Childbirth; 2014 Sep; 14():333. PubMed ID: 25258023
[TBL] [Abstract][Full Text] [Related]
19. Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects.
Alwan S; Reefhuis J; Rasmussen SA; Olney RS; Friedman JM;
N Engl J Med; 2007 Jun; 356(26):2684-92. PubMed ID: 17596602
[TBL] [Abstract][Full Text] [Related]
20. First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects.
Louik C; Lin AE; Werler MM; Hernández-Díaz S; Mitchell AA
N Engl J Med; 2007 Jun; 356(26):2675-83. PubMed ID: 17596601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
